BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 3084166)

  • 1. Levonorgestrel hormone releasing intrauterine system (Mirena) as a contraceptive in egg donors: case report.
    Kailasam C; Akande V; Gordon UD
    J Assist Reprod Genet; 2005 Mar; 22(3):137-40. PubMed ID: 16018245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
    Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
    Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses.
    Alvarez F; Brache V; Faundes A; Tejada AS; Thevenin F
    Contraception; 1996 Nov; 54(5):275-9. PubMed ID: 8934060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
    Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
    Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant use.
    Alvarez F; Brache V; Tejada AS; Faúndes A
    Contraception; 1986 Feb; 33(2):111-9. PubMed ID: 3084166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary and gonadal hormones in women during spontaneous and induced ovulatory cycles.
    Ross GT; Cargille CM; Lipsett MB; Rayford PL; Marshall JR; Strott CA; Rodbard D
    Recent Prog Horm Res; 1970; 26():1-62. PubMed ID: 4919092
    [No Abstract]   [Full Text] [Related]  

  • 9. Transdermal delivery of levonorgestrel.
    Friend DR
    Med Res Rev; 1991 Jan; 11(1):49-80. PubMed ID: 1899713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility control.
    Harper MJ
    Med Res Rev; 1982; 2(4):403-32. PubMed ID: 6757597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotrophins and steroid hormones in the blood and urine of prepubertal girls and other primates.
    Winter JS; Faiman C; Reyes FI; Hobson WC
    Clin Endocrinol Metab; 1978 Nov; 7(3):513-30. PubMed ID: 103663
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiology and pharmacology of female reproduction under the aspect of fertility control.
    Elger W
    Ergeb Physiol; 1972; 67():69-168. PubMed ID: 4574573
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.